By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a


SEARCH JOBS


Industry
Services






Company News
Amgen (AMGN) Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 9/3/2015 6:25:30 AM
The Alliance for Regenerative Medicine (ARM) Submits Comments To European Medicines Agency's Draft Guideline On Gene Therapy Medicinal Products 9/2/2015 11:40:15 AM
FDA And European Medicines Agency Accept Regulatory Applications For Boehringer Ingelheim's Gilotrif (afatinib) For Treatment Of Advanced Squamous Cell Carcinoma Of The Lung 8/25/2015 6:24:51 AM
European Medicines Agency Validates Gilead (GILD)’s Marketing Application For Single Tablet Regimen Containing Rilpivirine, Emtricitabine And Tenofovir Alafenamide (R/F/TAF) For HIV Treatment 8/21/2015 9:31:01 AM
Takeda (TKPYY) Announces European Medicines Agency Acceptance Of Ixazomib’s Marketing Authorization Application For Patients With Relapsed/Refractory Multiple Myeloma 8/21/2015 9:27:21 AM
Pfizer (PFE) Announces European Medicines Agency Validates Marketing Authorization Application For IBRANCE (Palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer 8/20/2015 10:18:42 AM
Gamida Cell Achieves Major Regulatory Milestone: FDA And European Medicines Agency Respond Positively to NiCord Phase III Study Design Outline 8/10/2015 6:13:08 AM
European Medicines Agency Grants Orphan Drug Designation To DCR-PH1, Dicerna (DRNA)'s Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1) 8/7/2015 9:04:55 AM
GW Pharma (GWPH) Receives FDA Fast Track And European Medicines Agency Orphan Designations For Intravenous Cannabidiol In The Treatment Of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE) 8/6/2015 11:01:41 AM
GW Pharma (GWPH) Receives FDA Fast Track And European Medicines Agency Orphan Designations For Intravenous Cannabidiol In The Treatment Of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE) 8/6/2015 8:56:00 AM
12345678910...
//-->